Lack of oversight and scrutiny creates opportunity for fraud and heightened risk for investors in any investment. The SEC is sounding the alarm as it relates to SPACs, writes a guest columnist for Reuters’ Breaking Views. But long-term sustainability of the SPAC market will rely on creating a comprehensive risk management framework – and clear regulatory guidelines – with stronger controls and safeguards, that ensure companies going public via SPACs have the same scrutiny as companies going public via traditional IPO. Until that happens, SPAC investors face several main risks. These include material misstatements, inadequate management due diligence, and inaccurate reporting. Read more.
Related Posts
RegTech Open Project Slates Direct Listing on London Exchange
The technology business said today that it expects to have a market capitalization upon listing of 60 million pounds ($76.5 million.
Patient Square Capital Acquires SOC Telemed Following DeSPAC and Stock Nosedive
The news comes 15 months after SOC went public via Healthcare Merger Corp. At that time, in October 2020, the enterprise value of the combined company was estimated at $720M. Since then, SOC Telemed shares plunged into penny-stock territory, closing at 71 cents on Tuesday.
Senior Apple Car Executive Sued by SEC Over 2020 SPAC Dealings While at Canoo
Ulrich Kranz, the former CEO of Canoo, and former Canoo CFO Paul Balciunas were sued in federal court in Los Angeles for allegedly providing unreasonable revenue projections. Kranz also was accused of misstating how much he was paid. The two men no longer work at Canoo.
Ex-UniCredit CEO’S SPAC Seeks $606M in Amsterdam IPO: Report
Pegasus Acquisition Co. Europe BV, backed by billionaire Bernard Arnault and French asset manager Tikehau Capital, will begin a private placement shortly, with a goal of completing the IPO around April 29